COMPOSITE FOR PREDICTING PROGNOSIS OF CANCER, INCLUDING MEDICINE TO MEASURE MRNA OF DOCK10 GENES OR EXPRESSION DEGREE OF PROTEIN CODED BY GENES, KIT INCLUDING SAME, AND APPLICATION THEREOF

摘要

The present invention relates to a composite to predict the prognosis of breast cancer, especially progesterone receptor negative breast cancer, a kit including the same, and a method to predict the prognosis of progesterone receptor negative breast cancer or to screen a spread, reoccurrence, or death inhibitor by using the kit or the composite. The present invention is capable of quickly and accurately predicting the spread, reoccurrence, and mortality of the progesterone receptor negative breast cancer by measuring a low expression of the DOCK10 genes. As such, the present invention is capable of particularly identifying patients, who are positive and negative to the prognosis of progesterone receptor negative breast cancer, thereby determining the spread, reoccurrence, and mortality of the cancer early and enabling the selection and application of a proper treatment to increase the survivability of the patients.;COPYRIGHT KIPO 2017